论文部分内容阅读
冠心舒片是上海长城生化制药厂生产治疗冠心病的药物。第二军医大学附属一院及病理生理教研室等对冠心舒片进行了大量的研究工作,为该药治疗缺血性脑血管病提供了理论和实验依据。1979年5月市卫生局组织扩大了临床医院并统一了临床考核标准。经半年多来对228例缺血性脑血管病的临床观察,总有效率达85%。为此,市卫生局于1979年12月4日召开了有医院、科研、药厂等三十个单位七十名代表参加的冠心舒
Coronary heart Shu tablets is the Shanghai Great Wall Biochemical Pharmaceutical Factory production of coronary heart disease drugs. The Second Affiliated Hospital of Second Military Medical University and Pathophysiology Department of Coronary Heart Shu films conducted a lot of research work for the drug treatment of ischemic cerebrovascular disease provides a theoretical and experimental basis. In May 1979, the Municipal Health Bureau expanded the clinical hospital and unified the clinical examination standard. After more than six months of 228 cases of ischemic cerebrovascular disease clinical observation, the total effective rate of 85%. To this end, the Municipal Health Bureau on December 4, 1979 held a hospital, scientific research, pharmaceutical and other 30 units of 30 representatives to participate in the Corolla